ArticleNEJM catalyst innovations in care delivery2025
Inpatient Telehepatology at Community Hospitals: Expanding Access and Comanaging Complex Care.
Article in NEJM catalyst innovations in care delivery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
The complexity of care for decompensated liver disease often necessitates the transfer of patients to tertiary care hospitals (TCHs) for management by advanced liver care teams. However, TCHs often have a wait list for transfers, which can lead to delays in timely care. These delays can increase the risk of medical errors, which can be compounded by the multiple handoffs and uncertainty during the transfer process. To address these limitations and reduce reliance on transfers, the Indiana University Health Hepatology team, based at the academic health center (AHC), implemented a remote inpatient telehepatology (INP-TH) consultation service for comanaging patients with advanced liver disease while they remain hospitalized at one of the integrated health care system's community hospitals. In this article, the authors describe the logistics, feasibility, and selected outcomes of the INP-TH service across three of the community hospitals. Multiple stakeholders at the community hospitals and from the health system leadership were engaged before establishing the service. The service was implemented at minimal additional cost, utilizing existing clinical staff and two patient-facing iPads at each community hospital. AHC-based dedicated inpatient hepatology physician assistants and hepatology attendings participated in the INP-TH consultations. Patients under evaluation in the ED or those receiving care in the ICU were not eligible for the INP-TH consultation request. The results presented are from the virtual consultations offered to 155 patients from July 1, 2022, to December 31, 2023. On establishing INP-TH, only 12 patients (8%) were transferred to the AHC at the discretion of the INP-TH team for reasons related to the severity of illness or specialized services only available at the AHC; the other 143 (92%) were comanaged locally. Of the 155 patients, 57% had an outpatient hepatology follow-up within 30 days, 28% were readmitted to a hospital within 30 days, and 8% died within 30 days, which included nine as inpatients and four as outpatients. Provider engagement and satisfaction surveys revealed strong support and high satisfaction levels from both hepatology providers and hospitalists, with no readily evident risk to the patients. The INP-TH initiative models an approach for locally comanaging patients with complex or advanced diseases by establishing the feasibility and efficacy of comanagement of patients with decompensated cirrhosis at community hospitals without the need for physical transfer. To enhance its scale and breadth, the adaptation and expansion of the service to other health care systems should be explored.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.